Genetic diversity, drug resistance, and transmission patterns of tuberculosis based on whole-genome sequencing in Almaty, Kazakhstan

基于哈萨克斯坦阿拉木图全基因组测序的结核病遗传多样性、耐药性和传播模式

阅读:1

Abstract

Tuberculosis, particularly multidrug-resistant TB (MDR-TB), remains a major public health concern in Kazakhstan, where 26% of new TB cases are MDR, far exceeding the global average. To better understand the genetic diversity, drug resistance, and transmission dynamics of Mycobacterium tuberculosis in Kazakhstan, we conducted a retrospective study at the National Scientific Center of Phthisiopulmonology in Almaty from 2023 to 2024. Whole-genome sequencing (WGS) was performed on 272 culture-confirmed TB isolates collected from patients across the country. Phylogenetic analysis revealed the predominance of Lineage 2 (East Asian genotype, 72.4%) and Lineage 4 (Euro-American genotype, 26.8%). Drug resistance profiling identified 29.0% of isolates as MDR-TB, of which 3.3% were classified as pre-XDR and 0.7% as XDR. The most frequently observed resistance-associated mutations were katG S315T (99.2%) and rpoB S450L (91.1%). Cluster analysis using a ≤ 12 SNP threshold identified 22 genomic clusters involving 80 isolates (29.4%), indicating recent and possibly ongoing transmission. Spatial mapping showed that nearly 60% of clusters spanned multiple regions, while others were highly localized, suggesting household or close-contact transmission. A Mantel correlogram test revealed a statistically significant correlation between geographic and genomic SNP distances in Almaty and Almaty Region (r = 0.0634, p = 0.041) within the first distance class (average 5 km, range 0-8 km). These findings suggest that patients living in close proximity are more likely to carry genetically similar strains. As distance increases, geographic proximity becomes less predictive of transmission, with other factors-such as mobility, shared environments, or healthcare contact-likely playing a greater role. Our findings underscore the need to integrate WGS into national TB control programs to guide targeted interventions, enhance surveillance, and curb the spread of drug-resistant TB strains across Kazakhstan.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。